Nutra Pharma Corp. (NPC) :: NPC Blog

Nutra Pharma Provides Sales and Marketing Update

Corporate Communications — Thu, 20 Dec 2012 20:47:20 +0000

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma’s over-the-counter (OTC) pain reliever, Nyloxin™. Coral Springs, FL. – December 20, 2012 – Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is providing updates on the sales and marketing activities of TCN, a distributor of Nutra Pharma’s over-the-counter (OTC) pain reliever, Nyloxin™. In September 2012, Nutra Pharma announced the beginning of distribution efforts by the TCN group of direct distributors. Since that time, TCN has worked diligently to introduce Nyloxin™ to approximately 40,000 distributors in the United States and almost 400,000 distributors globally. Sales to individual consumers have already begun in the US, Europe, Asia and Africa. Additionally, TCN has scheduled marketing efforts in the US that will include internet, radio and television. Read the entire press release

Nutra Pharma Introduces Nyloxin™ Military Strength

Corporate Communications — Wed, 19 Dec 2012 14:24:29 +0000

Nutra Pharma is introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™, and has begun the process of registration with the United States government for sales into the military.

Coral Springs, FL. – December 19, 2012 – Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™. The new product will be called Nyloxin™ Military Strength.

Over the past few years, the U.S. Department of Defense has been reporting an increase in the use and abuse of prescription medications, particularly opiates. In 2009, close to 3.8 million prescriptions for pain relievers were written in the military. This staggering number was more than a 400% increase from the number of prescriptions written in the military in 2001. But prescription drugs are not the only issue.

Click here to read the entire article

Nutra Pharma Letter to Shareholders

Corporate Communications — Tue, 18 Dec 2012 14:45:50 +0000

Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company.

December 18, 2012 — Coral Springs, Florida — Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the Company’s Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company’s website.

“We have been very busy here at Nutra Pharma,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “I wanted to take this opportunity to update our shareholders and the public on the status of the Company and briefly outline our goals and expectations for the coming months,” he concluded.

Click here to read on…

As Seen In USA Today World Series Preview

Corporate Communications — Mon, 12 Nov 2012 21:02:11 +0000

Click here to see our ad on page 25 of the special USA Today MLB World Series Preview Sports Weekly.